MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹78 Cr | ₹85 Cr | ₹83 Cr | ₹73 Cr | ₹53 Cr |
What is the latest Total Current Liabilities ratio of MEDICAMEN BIOTECH ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹78 Cr |
| Mar2024 | ₹85 Cr |
| Mar2023 | ₹83 Cr |
| Mar2022 | ₹73 Cr |
| Mar2021 | ₹53 Cr |
How is Total Current Liabilities of MEDICAMEN BIOTECH Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹78 Cr | -7.56 | |
| Mar2024 | ₹85 Cr | 2.40 | |
| Mar2023 | ₹83 Cr | 13.60 | |
| Mar2022 | ₹73 Cr | 36.45 | |
| Mar2021 | ₹53 Cr | - | |
Compare Total Current Liabilities of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹480.3 Cr | -0.2% | -7.6% | -28.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹393,323.0 Cr | 1.7% | -5.7% | -7.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,825.0 Cr | 0.8% | -6.7% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,349.0 Cr | 0.6% | 4.3% | 24.4% | Stock Analytics | |
| CIPLA | ₹106,048.0 Cr | -4.7% | -12.3% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,494.0 Cr | 6.3% | -2.1% | -4.1% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | -0.2% |
-7.6% |
-28.2% |
| SENSEX | -1.7% |
-4.3% |
6.2% |
You may also like the below Video Courses